Cannassure Therapeutics Ltd (TA:CSURE) — Market Cap & Net Worth
Market Cap & Net Worth: Cannassure Therapeutics Ltd (CSURE)
Cannassure Therapeutics Ltd (TA:CSURE) has a market capitalization of $217.46K (ILA81.11 Million) as of September 18, 2026. Listed on the TA stock exchange, this Israel-based company holds position #31312 globally and #463 in its home market, demonstrating a -7.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cannassure Therapeutics Ltd's stock price ILA571.10 by its total outstanding shares 51166800 (51.17 Million).
Cannassure Therapeutics Ltd Market Cap History: 2015 to 2026
Cannassure Therapeutics Ltd's market capitalization history from 2015 to 2026. Data shows growth from $16.37 Million to $78.34 Million (17.38% CAGR).
Cannassure Therapeutics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cannassure Therapeutics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CSURE stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CSURE by Market Capitalization
Companies near Cannassure Therapeutics Ltd in the global market cap rankings as of September 18, 2026.
Key companies related to Cannassure Therapeutics Ltd by market ranking:
- LabGenomics Co. Ltd (KQ:084650): Ranked #29512 globally with a market cap of $3.08 Million USD ( ₩4.54 Billion KRW).
- Rajvir Industries Limited (NSE:RAJVIR): Ranked #31303 globally with a market cap of $229.84K USD ( Rs21.25 Million INR).
- HPI AG (MU:CEW3): Ranked #31313 globally with a market cap of $215.77K USD ( €184.56K EUR).
- Symphony Environmental Technologies plc (LSE:SYM): Ranked #31314 globally with a market cap of $215.69K USD ( GBX1.77 Billion GBX).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #29512 | LabGenomics Co. Ltd | KQ:084650 | $3.08 Million | ₩500.00 |
| #31303 | Rajvir Industries Limited | NSE:RAJVIR | $229.84K | Rs5.32 |
| #31313 | HPI AG | MU:CEW3 | $215.77K | €0.02 |
| #31314 | Symphony Environmental Technologies plc | LSE:SYM | $215.69K | GBX7.50 |
Cannassure Therapeutics Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Cannassure Therapeutics Ltd's market cap moved from $16.37 Million to $ 78.34 Million, with a yearly change of 17.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA78.34 Million | -21.53% |
| 2025 | ILA99.84 Million | -7.30% |
| 2024 | ILA107.70 Million | +1525.47% |
| 2023 | ILA6.63 Million | -13.13% |
| 2022 | ILA7.63 Million | +39.70% |
| 2021 | ILA5.46 Million | -62.02% |
| 2020 | ILA14.38 Million | -5.84% |
| 2019 | ILA15.27 Million | -38.17% |
| 2018 | ILA24.69 Million | +128.72% |
| 2017 | ILA10.80 Million | -3.91% |
| 2016 | ILA11.23 Million | -31.35% |
| 2015 | ILA16.37 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Cannassure Therapeutics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $217.46K USD |
| MoneyControl | $217.46K USD |
| MarketWatch | $217.46K USD |
| marketcap.company | $217.46K USD |
| Reuters | $217.46K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cannassure Therapeutics Ltd
CannAssure Ltd cultivates and produces medical cannabis. The company was incorporated in 2017 and is headquartered in Ashdod, Israel.